Robert Goldman

7.0k citations
100 papers · 5.4k · 2 hit papers · h-index 35

Impact in

Papers in

Robert Goldman

99 papers receiving 5.1k citations

Robert Goldman's Hit Papers

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia 2020 · 212 citations
2120+9+18Years since publication2505007501000

Peers

Robert Goldman
Comparison fields: 5 of 119
  • Psychiatry and Mental health 3.4k
  • Biological Psychiatry 302
  • Cognitive Neuroscience 1.0k
  • Philosophy 599
  • Clinical Psychology 748
Replace Miranda Chakos with:
Miranda Chakos United States
Jean‐Pierre Lindenmayer United States
Brian Sheitman United States
Víctor Peralta Spain
Brian Toone United Kingdom
Don Linszen Netherlands
Ofer Agid Canada
M F Green United States
Alan I. Green United States
Larry Alphs United States
Robert Goldman relative to Miranda Chakos United States Miranda Chakos's profile →
Citations per field
00.5×1.5×2.2×
Miranda Chakos · 1×
Citations per year

Countries citing papers authored by Robert Goldman

Since Specialization
Citations

This map shows the geographic impact of Robert Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Goldman more than expected).

Fields of papers citing papers by Robert Goldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Goldman. The network helps show where Robert Goldman may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Goldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Goldman Line = papers co-authored together Robert Goldman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Hit paper breakdown →
19991017
2 2002437
3 1999368
4 2007325
5 2002278
6
A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Hit paper breakdown →
2020212
7 1998148
8 1991142
9 2000137
10 2001132
11 2007113
12 2002103
13 200698
14 199394
15 201090
16 200085
17 200378
18 201772
19 202166
20 199666

About Robert Goldman

Robert Goldman is a scholar working on Psychiatry and Mental health, Clinical Psychology, Cognitive Neuroscience, Experimental and Cognitive Psychology and Pharmacology, having authored 100 papers that have together received 5.4k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (38 papers), Attention Deficit Hyperactivity Disorder (20 papers), Bipolar Disorder and Treatment (15 papers), Functional Brain Connectivity Studies (9 papers), Dementia and Cognitive Impairment Research (9 papers), Treatment of Major Depression (8 papers), Pharmaceutical studies and practices (7 papers) and Mental Health and Psychiatry (7 papers). The work is most often cited by research in Psychiatry and Mental health (3.4k citations), Biological Psychiatry (302 citations), Cognitive Neuroscience (1.0k citations), Philosophy (599 citations) and Clinical Psychology (748 citations). Robert Goldman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert M. Bilder, Jeffrey A. Lieberman, Delbert G. Robinson, Margaret G. Woerner, Brian Sheitman, Miranda Chakos, A. Koreen, Jose Ma. J. Alvir, Stephen Geisler and David Mayerhoff. Their work appears in journals such as Journal of the American Academy of Child & Adolescent Psychiatry, Biological Psychiatry, CNS Spectrums, Schizophrenia Research and American Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact